Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • usfda

    Tag: usfda

    You Searched For "usfda"
    Novartis sickle cell drug crizanlizumab secures speedy USFDA review

    Novartis sickle cell drug crizanlizumab secures speedy USFDA review

    Medical Dialogues Bureau17 July 2019 9:26 AM IST
    Novartis submitted the application for crizanlizumab for the prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and...
    USFDA issues warning letter to Indoco Remedies for Goa plant

    USFDA issues warning letter to Indoco Remedies for Goa plant

    Medical Dialogues Bureau16 July 2019 11:39 AM IST
    The facility had received six observations in Form 483s and was classified as Official Action Indicated in March. Indoco Remedies responded to these...
    Natco Pharma gets zero USFDA observations for Chennai facility

    Natco Pharma gets zero USFDA observations for Chennai facility

    Medical Dialogues Bureau16 July 2019 9:30 AM IST
    Natco Pharma announced "successful completion of regulatory inspection from the US Food and Drug Administration (USFDA) for its active pharmaceutical...
    Lupin to focus on launch of biosimilar, inhalation product in US this fiscal

    Lupin to focus on launch of biosimilar, inhalation product in US this fiscal

    Medical Dialogues Bureau15 July 2019 9:45 AM IST
    Coupling this with the building of Solosec brand in the US, NaMuscla in Europe and Bipresso in Japan will help Lupin drive sustainable growth, they...
    Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer

    Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer

    Medical Dialogues Bureau10 July 2019 10:00 AM IST
    Lupin's Imatinib Mesylate Tablets, 100mg (base) and 400mg (base), is the generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec...
    Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor

    Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor

    Medical Dialogues Bureau9 July 2019 12:49 PM IST
    Mumbai: Sun Pharma Advanced Research Company (SPARC) on Monday said the US health regulator has given orphan drug designation to its novel kinase...
    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Medical Dialogues Bureau8 July 2019 1:32 PM IST
    As part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
    Zydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcers

    Zydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcers

    Medical Dialogues Bureau5 July 2019 11:52 AM IST
    New Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod from the US health regulator to market its generic Misoprostol tablets...
    Elizabeth Warren asks former USFDA chief Gottlieb to QUIT Pfizer board

    Elizabeth Warren asks former USFDA chief Gottlieb to QUIT Pfizer board

    Medical Dialogues Bureau5 July 2019 9:10 AM IST
    In a letter to Gottlieb, Warren, who is seeking the Democratic nomination for the 2020 presidential election, said "this kind of revolving door...
    Lupin gets USFDA nod for generic versions of Sensipar tablets, Omidria intraocular solution

    Lupin gets USFDA nod for generic versions of Sensipar tablets, Omidria intraocular solution

    Medical Dialogues Bureau4 July 2019 9:45 AM IST
    Cinacalcet tablets are a generic version of Amgen Inc's Sensipar tablets in the same strengths, said Lupin.New Delhi: Drug firm Lupin on Wednesday...
    Alembic Pharma gets USFDA nod for generic version of Uloric tablets

    Alembic Pharma gets USFDA nod for generic version of Uloric tablets

    Farhat Nasim2 July 2019 11:49 AM IST
    The approved product, Febuxostat tablet is therapeutically equivalent to the reference listed drug Uloric tablets of Takeda Pharmaceuticals USA, Inc....
    Alembic Pharma gets USFDA nod for Clonazepam orally disintegrating tablets

    Alembic Pharma gets USFDA nod for Clonazepam orally disintegrating tablets

    Farhat Nasim1 July 2019 12:25 PM IST
    The approval from the United States Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Clonazepam...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok